Press Releases from Type 2 Diabetes (3 total)
Exclusive Forecast Study: PharmaPoint: Type 2 Diabetes - Global Drug Forecast an …
ResearchMoz presents professional and in-depth study of "PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026". This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future.
Summary
While the global T2D market is crowded with inexpensive generics and marked by a pipeline filled with me-too drugs, GlobalData expects this market to undergo substantial growth between…
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate P …
Albany, NY, Feb 27, 2017: Type 2 diabetes mellitus (T2DM) is a chronic, progressive and serious metabolic disorder characterized by hyperglycemia (high blood glucose levels) and associated with numerous complications and co-morbidities, including cardiovascular, renal and neurodegenerative diseases.
Global prevalence of the disease has risen rapidly in the past several decades, primarily as a result of rising obesity, a major risk factor for T2DM. This has resulted in a large and…
Type 2 Diabetes Mellitus Therapeutics In South-East Asia Markets To 2022 - Incre …
Worldwide Market studies the current scenario as well as future market potential of "Type 2 Diabetes Mellitus Therapeutics In South-East Asia Markets To 2022 - Increasing Usage Of Newer Therapies And Expanding Treatment Population To Encourage Robust Growth"
Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these. This…
